A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RAEB / RA with excess of blasts

[Related PubMed/MEDLINE]
Total Number of Papers: 119
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RAEB  (>> Co-occurring Abbreviation)
Long Form:   RA with excess of blasts
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2014 [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome]. aGVHD, allo-HSCT, AML, BU, cGVHD, CY, DFS, Flu, G-CSF, HLA, IPSS, MDS, NRM, OS, RA, RAEB-t, RR
2  2013 A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. MDS, OR, RA, RAEB-t, RARS
3  2010 [Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome]. BM, CsA, MDS, RA
4  2009 Primary myelodysplastic syndrome in Jordan: a single-centre experience. MDS, RA
5  2009 [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases]. CMML, CR, HI, MDS, PR
6  2008 Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia. AML, AZA, CR, HI, HI, MDS, RA
7  2008 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. hMDS, INT-1, IPSS, MDS, NH-MDS, RA
8  2008 Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes. CMML, IPSS, MDS, RA, RAEB-t, RARS
9  2008 The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. MDS, RA, RARS, XLSA/A
10  2008 [An analysis of prognostic factors in 80 myelodysplastic syndrome]. IPSS, MDS, RA, RCMD
11  2006 Darbepoetin alpha for the treatment of anemia in patients with myelodysplastic syndromes. DA, ESP, MDS, RA, rHuEPO
12  2006 Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. AML, FAB, MDS, RA, RARS, RCMD, RCMD-RS, WHO
13  2006 [Allogenic stem cell transplantation from genotypically HLA-identical siblings for 30 patients with myelodysplastic syndromes]. allo-HSCT, BMT, DFS, MDS, OS, PBSCT, RA, RAEB-t, RARS
14  2006 [Effect of TCM syndrome-typing based therapy combined with cyclosporin in treating myelodysplastic syndrome]. MDS, RA, TCM-STBT
15  2005 NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). ATO, Bcl-XL, BMMCs, FADD, MDS, MDSs, NF-kappaB, RA/RARS, TNF, XIAP
16  2005 Risk factors of myelodysplastic syndromes: a case-control study. CMML, FAB, MDS, OR, RA, RAEB-t, RARS
17  2004 Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. BMT, CMML, EFS, JMML, MDS, RA, RAEB-t, RARS
18  2004 Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases. BMA, BMB, MDS, PB, RA, RAEB-t
19  2004 Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells. ATG, MDS, RA
20  2004 Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. CMML, IL-1beta, MDS, RA, RAEB-t, RARS, sICAM-1, sVCAM-1
21  2004 Long-term survivors in myelodysplastic syndromes: clinical and biological characteristics. MDS, RA, RARS
22  2004 Transformation of myelodysplastic syndromes into acute myeloid leukemias. AML, MDSs, RA, RAEB-t
23  2004 [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients]. MDS, RA, RARS, RCMD
24  2004 [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis]. BMMNCs, DDIT3, ETV1, GSPT1, MAD, MDS, PTEN, RA, RAEB-t, RNAHP, RTC, THBS1
25  2003 Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes. ATG, i.v, MDS, RA, RARS
26  2003 Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. FADD, MDS, RA, RAEB-t, RIP, RT, TNF, TNFR, TRADD, TRAF2
27  2003 Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. HF, MtF, RA, RARS, XLSA
28  2003 Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes. FAB, HCT, MDS, RA, RAEB-t
29  2003 Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. AA, BM, PNH, RA
30  2003 Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. IPSS, MDS, RA, RQ-PCR, sAML
31  2003 [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. AML, MDS, RA, RAEB-t, RAS
32  2003 [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia]. AL, MDS, RA, RAEB-t, RT-PCR, WT1
33  2002 Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. AML, HLA, IL-10, LTalpha, MDS, RA, RAEB-t, TNF-alpha
34  2002 Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. AL-MDS, EBCs, MDS, RA
35  2002 Detection of risk groups in myelodysplastic syndromes. A multicenter study. FAB, IPSS, LE, MDS, RA, SV
36  2002 Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome. AA, ELISA, IPSS, MDS, RA
37  2002 Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. ALL, AML, CML, MDS, RA, RAEB-t
38  2002 Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. CI, MDS, OR, RA, RAEB-t, RR, TRM
39  2001 Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes. AML, BMMNC, EPO, IL-3, MDS, RA, RAEB-t, RT-PCR, SCF
40  2001 Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes. FAB, MDS, RA
41  2001 Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. epo, Hb, MDS, RA, rHuEPO
42  2001 Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. AML, MDS, RA
43  2001 [Apoptosis and proliferative activity of bone marrow cells in patients with aplastic syndromes as evidenced by trephine biopsy]. ANLL, CsA, LGM, RA, RAEB-t
44  2000 Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. BMT, CI, CMML, CY, DSF, FAB, FTBI, IPSS, KM, MDS, RA
45  2000 Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. AML, MDS, RA
46  2000 Differential cellular expression of the human MSH2 protein in normal and myelodysplastic haematopoiesis. hMSH2, MDS, RA, RAEB-t, RARS
47  2000 Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. ANC, MDS, RA, RAEB-t, TNF
48  2000 Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes. AML, CMMoL, MDS, RA, RAEB-t, RARS
49  2000 Function and X chromosome inactivation analysis of B lymphocytes in myelodysplastic syndromes with immunological abnormalities. IA, IL, MDS, RA, XCIP
50  2000 Myelodysplastic syndromes in children. A critical review of the clinical manifestations and management. BMT, JCML, Mo7, RA
51  2000 Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. ANC, CMMoL, MDS, RA, RARS
52  2000 Prevalence and survival of myelodysplastic syndrome of the refractory anemia type in hospitalized cognitively different geriatric patients. MDS, RA
53  2000 Thrombopoietin and myelodysplastic syndromes. MDS, RA, RAEB-t, TPO, TPO-R
54  2000 Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. CI, MDS, RA, RARS, rhEPO, rhG-CSF
55  2000 [Chromosome 1 abnormalities at band 1p32 in two atomic bomb survivors with myelodysplastic syndrome]. MDS, RA
56  1999 Biologic characteristics of 164 patients with myelodysplastic syndromes. BM, ISEL, MDS, RA, RAEB-t, RARS, TNF-alpha
57  1999 Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes. MDS, MK, RA, RAEB-t, RARS
58  1999 Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis. MDS, PGK, RA, RARS
59  1999 Flow-cytometric analysis of leukocyte alkaline phosphatase in myelodysplastic syndromes. G-CSF, LAP, MDS, RA
60  1999 Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). AML, BMT, EWOG-MDS, JMML, MDS, RA, RAEB-t
61  1999 Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis. IHC, MDS, RA
62  1999 The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. AML, BM, MDS, PB, RA, RAEB-t
63  1999 Treatment of anemia in low risk myelodysplastic syndromes with granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin. MDS, RA, RAS
64  1999 [Refractory anemia and preleukemia: an analysis of 92 cases]. AL, PL, RAEB-t
65  1998 A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. FasL, MDS, RA, RAEB-t
66  1998 Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome. AML, CMML, MDS, PCR-ASO, RA, RAEB-t, RARS
67  1998 Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes. CMML, MDS, RA, RAEBt, TPO
68  1998 Epidemiology of myelodysplastic syndromes in a French general hospital of the Basque country. CMML, MDS, RA, RARS
69  1998 Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes. MDS, RA, RAEB-t, TPO, TPO-R
70  1998 Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. AML, MDS, RA, RAEB-t, RARS, TUNEL
71  1997 Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. MDS, RA, RAEB-t
72  1997 Telomere length in myelodysplastic syndromes. CMMLt, MDS, RA, RAEB-t, TRA
73  1997 The natural history of trilinear myelodysplastic syndrome and erythroleukemia. AML, MDS, RA
74  1997 Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children. BMT, GVHD, JCML, RA, RAEB-t
75  1996 Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML. RA
76  1995 Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome. BM, MDS, MDS, PB, RA
77  1995 Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. CMML, JPN, MDS, RA, RAEB-t, RARS
78  1995 Prevalence of the myelodysplastic syndromes in Japan. CMML, MDS, RA
79  1995 Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. AA, MDS, PBMC, RA, RAEB-t
80  1995 [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome]. CMMoL, MDS, RA, RAEB-t, RARS
81  1994 Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. AML, MDS, RA, RAEB-t, RARS
82  1994 Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. GM-CSF, MDS, PCR, PGK, RA, RFLP, SCF
83  1994 Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. EPO, GM-CSF, IL-6, MDS, RA, RA/RARS, SCF
84  1994 Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes. BMT, GVHD, JCML, MDS
85  1994 Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features. MAKA, MDS, RA
86  1994 Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses. BM, RA
87  1994 Serum deoxythymidine kinase in myelodysplastic syndromes. AML, CMML, LDH, MDS, RA, RAEB/T, RARS, S-TK
88  1993 A randomized phase II trial of low-dose aclarubicin vs very low-dose cytosine arabinoside for treatment of myelodysplastic syndromes. GR, LC-ACR, MDS, PR, RA, RAEB-t, VLD-AC
89  1993 All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. APL, ATRA, MDS, RA, RAEB/T, RARS
90  1993 Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. CMML, HPRT, MDS, PGK, RA, RAEB-t, RARS, RFLP
91  1993 Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites. ANLL, ET, MDS, PRV, RA, RAEB-t, RARS
92  1993 Myelodysplastic syndrome with eosinophilia in bone marrow. Gunma Haematology Study Group. MAKA, MDS, RA
93  1993 Relationship between autoantibody and dermatosis in myelodysplastic syndrome. ANA, CMMoL, MDS, RA, RAEB-t, RARS, RF
94  1993 Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. GM-CSF, LPS, MDS, ORR, PBMC, RA, TNF-alpha
95  1993 Treatment of myelodysplastic syndromes with all-trans retinoic acid. Leukemia Study Group of the Ministry of Health and Welfare. ATRA, MDS, RA, RAEB-t
96  1992 Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. CMML, RA, RAEB-t
97  1992 Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. CMML, MDS, PSA, RA, RAEB/T, RARS
98  1992 Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. ALIP, BMB, CMML, FAB, PMDS, RA, RAEB-t, RARS
99  1991 Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome. CMML, MDS, RA, RAEB-t, RARS
100  1991 Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. CFU-GM, MDS, RA, RARS, rHuEPO